Skin equity — the principle that every patient should receive comparable dermatologic care regardless of geography, income, or skin tone — will not be achieved with a one-size-fits-all agenda, according to a new Medscape report, "Achieving Global 'Skin Equity' Requires Targeted Approach."

The report's central argument is architectural rather than aspirational. Broad commitments to equality in dermatologic care, however loudly declared, do not close outcome gaps on their own. What moves the needle, the piece contends, is a targeted approach: interventions designed around the specific populations, disease burdens, and health-system constraints that produce inequity in the first place.

That framing matters for a specialty with one of the widest recorded spreads between burden and capacity. Skin conditions rank among the most prevalent causes of disability worldwide, yet dermatologic expertise remains concentrated in high-income urban centers. The resulting mismatch — high prevalence, thin specialist coverage — falls hardest on the communities least equipped to absorb it.

A targeted approach, as the report's title implies, starts from the recognition that inequity is not a single problem. Access barriers, diagnostic blind spots, treatment costs, and gaps in workforce training each demand their own remedy. Programs that bundle these together under a generic equity banner risk dissipating resources across too many fronts. Programs that pick a defined problem — a specific population, a specific disease, a specific bottleneck in care delivery — can be measured, iterated, and scaled.

The phrase "global" in the report's title is doing deliberate work. Skin equity is often framed as a domestic issue, centered on disparities within individual health systems. The Medscape piece widens the aperture: the inequities that shape dermatologic outcomes cross borders, and the strategies to correct them must be designed with that scale in mind.

For clinicians, the practical question the report raises is where targeting should begin. Every dermatology practice sits somewhere on the gradient between burden and access, and the data needed to locate that position — who is not being seen, which conditions go undiagnosed, which treatments go unfilled — already exist in most practices' own records. A targeted approach does not necessarily require new infrastructure; it requires the discipline to ask which patients the current system is failing, and then to build the response around them.

The report's title also carries an implicit caution for the field's institutions. Equity statements and diversity commitments have multiplied across dermatology in recent years. The Medscape framing suggests that the next phase of this work will be judged not by the breadth of its ambition but by the precision of its execution — whether the specialty can match its stated goals with interventions pointed at defined, measurable gaps in skin health.

How dermatology converts the equity agenda into targeted, outcome-bearing programs across different health systems will define whether "skin equity" remains a slogan or becomes a standard of care.